Fusion Pharm Stock Forecast - Naive Prediction
| FSPM Stock | USD 0.0001 0.00 0.00% |
The Naive Prediction forecasted value of Fusion Pharm on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Fusion Stock Forecast is based on your current time horizon. Although Fusion Pharm's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Fusion Pharm's systematic risk associated with finding meaningful patterns of Fusion Pharm fundamentals over time.
Fusion |
Fusion Pharm Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Fusion Pharm's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2010-12-31 | Previous Quarter 2.5 K | Current Value 2.4 K | Quarterly Volatility 8 K |
Fusion Pharm Naive Prediction Price Forecast For the 3rd of December
Given 90 days horizon, the Naive Prediction forecasted value of Fusion Pharm on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Fusion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Fusion Pharm's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Fusion Pharm Stock Forecast Pattern
| Backtest Fusion Pharm | Fusion Pharm Price Prediction | Buy or Sell Advice |
Fusion Pharm Forecasted Value
In the context of forecasting Fusion Pharm's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Fusion Pharm's downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Fusion Pharm's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Fusion Pharm stock data series using in forecasting. Note that when a statistical model is used to represent Fusion Pharm stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.385 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Fusion Pharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fusion Pharm. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Fusion Pharm
For every potential investor in Fusion, whether a beginner or expert, Fusion Pharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fusion. Basic forecasting techniques help filter out the noise by identifying Fusion Pharm's price trends.Fusion Pharm Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fusion Pharm stock to make a market-neutral strategy. Peer analysis of Fusion Pharm could also be used in its relative valuation, which is a method of valuing Fusion Pharm by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Fusion Pharm Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fusion Pharm's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fusion Pharm's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Fusion Pharm Market Strength Events
Market strength indicators help investors to evaluate how Fusion Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharm shares will generate the highest return on investment. By undertsting and applying Fusion Pharm stock market strength indicators, traders can identify Fusion Pharm entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Fusion Pharm to cross-verify your projections. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.